Moreover, implantation of JAK2V617F AML cell lines with HMGA1 deficiency in immunosuppressed mice results in decreased engraftment of leukemic blasts in the bone marrow and spleen, together with a lower frequency of circulating leukemia blasts [48]. This evidence concerns the gene HMGA1 and acute myeloid leukemia.